Arcturus Therapeutics Holdings Inc. (ARCT) Institutional Ownership

Ownership Summary

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) appears in 118 institutional 13F filings for the quarter ending December 2025.

• They owned 87.3% of outstanding stock in December 2025, down from 98.2% the prior quarter.
• Their total shares held in ARCT decreased -2.04% quarter over quarter, and separately, investors owning Arcturus Therapeutics Holdings decreased 19.73% from a year ago.
• Among the 118 funds, 63 bought more Arcturus Therapeutics Holdings shares, 37 sold down, and 18 held their ground.
• Altogether, these fund groups held 23.74Mn shares in ARCT by December 2025, down by 494.67K shares quarter on quarter, and down 3.55Mn shares year over year.
• As of December 31, 2025, the biggest holder of Arcturus Therapeutics Holdings is Federated Hermes, Inc. at 3.3Mn shares, representing 12.15% of shares outstanding.
• The most significant purchases of ARCT for the quarter ending December 2025 came from VANGUARD CAPITAL MANAGEMENT LLC (1.11Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (977.92K), TWO SIGMA INVESTMENTS, LP (535.1K), Amova Asset Management Americas, Inc. (262.35K), Sumitomo Mitsui Trust Group, Inc. (262.35K).
• Top sellers of ARCT stock for the quarter ending December 2025 included Goldman Sachs Group Inc (583.77K), JANE STREET GROUP, LLC (399.34K), DIMENSIONAL FUND ADVISORS LP (202.07K), Point72 Asset Management, L.P. (158.32K), ACADIAN ASSET MANAGEMENT LLC (147.39K).
• Business Quant data shows the 10 biggest positions in Arcturus Therapeutics Holdings as of December 2025 are held by Federated Hermes, Inc. (3.3Mn), ARK Investment Management LLC (2.77Mn), BlackRock, Inc. (2.61Mn), Amova Asset Management Americas, Inc. (2.29Mn), Sumitomo Mitsui Trust Group, Inc. (2.29Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.11Mn), TWO SIGMA INVESTMENTS, LP (1.08Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (977.92K), GEODE CAPITAL MANAGEMENT, LLC (660.93K), State Street Corp (543.86K).